Advertisement
Screener

J. Goldman & Co LP Historic Quarter Change: USA Rights, Sold Out

J. Goldman & Co LP historic quarter change: USA Rights, Sold out

In rights (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, J. Goldman & Co LP opened 2 positions, added to 3, reduced 1 and sold out of 3.

  • Q3 2014: Stock SANOFI; Country of operation —; Class RIGHT 12/31/2020; Shares before 400,000.
  • Q3 2014: Stock CUBIST PHARMACEUTICALS INC; Country of operation —; Class RIGHT 99/99/9999; Shares before 164,708.
  • Q4 2013: Stock CELGENE CORP; Country of operation —; Class RIGHT 12/31/2030; Shares before 40,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1412741), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-10); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-12-15); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-18); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2011-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2014SANOFI
CUSIP 80105N113
RIGHT 12/31/2020400,0000-400,000$200,000$0-$200,0002014-11-14
Q3 2014CUBIST PHARMACEUTICALS INC
CUSIP 229678123
RIGHT 99/99/9999164,7080-164,708$19,000$0-$19,0002014-11-14
Q4 2013CELGENE CORP
CUSIP 151020112
RIGHT 12/31/203040,0000-40,000$322,000$0-$322,0002014-02-14

Similar Firms

Firm NameCountry13F ValueHoldings
Caledonia (Private) Investments Pty LtdAustralia$3.438B16
SPROTT INC.Canada$3.437B243
Performance Wealth Partners, LLCUnited States$3.447B212
Richard Bernstein Advisors LLCUnited States$3.448B227
CHECK CAPITAL MANAGEMENT INC/CAUnited States$3.436B66
PAR CAPITAL MANAGEMENT INCUnited States$3.452B48
LINCOLN NATIONAL CORPUnited States$3.454B19
Davis Asset Management, L.P.United States$3.456B85
ONTARIO TEACHERS PENSION PLAN BOARDCanada$3.459B162
Fisher Funds Management LTDNew Zealand$3.412B169